Skip to main content

Advertisement

Log in

Change of paradigm in treating elderly with breast cancer: are we undertreating elderly patients?

  • Review Article
  • Published:
Irish Journal of Medical Science (1971 -) Aims and scope Submit manuscript

Abstract

Developed countries face significant population ageing in the near future. Within 20 years, the average age will approach 50 years and the largest population cohort will be those over 65 years. The incidence of breast cancer increases with age, with a risk in women of 0.44% by the age of 30, 3.82% by the age of 70 and 10% by the age of 80. Breast cancer is responsible for one out of every three cancer-related deaths. Elderly patients have higher mortality rates and most breast cancer-related deaths are observed in women over 65. There appears to be a trend that elderly patients with breast cancer receive less than the standard treatment compared to younger counterparts and this leads to poorer outcomes. The rationale for treating elderly breast cancer patients more conservatively is that breast cancers in this cohort are more commonly oestrogen receptor (ER) positive which gives the clinician the option to treat with hormonal manipulation alone. In addition, elderly patients present at a later stage compared to younger patients who frequently present with early (stages I and II) breast cancer. This review aims to give an overview of the diagnosis, treatment options and surveillance of breast cancer in elderly women (over 75 years) and to discuss the change in perception of the term ‘elderly’ and the reasons for undertreatment in the elderly patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Harper S (2006) Ageing societies: myths, challenges and opportunities. https://trove.nla.gov.au/version/24983081. Accessed Nov 2017

  2. Passage K, McCarthy N (2007) Critical review of the management of early-stage breast cancer in elderly women. Intern Med J 37:181–189

    Article  CAS  PubMed  Google Scholar 

  3. Schairer C, Mink PJ, Carroll L, Devesa SS (2004) Probabilities of death from breast cancer and other causes among female breast cancer patients. J Natl Cancer Inst 96:1311–1321

    Article  PubMed  Google Scholar 

  4. Rao VSR, Jameel JK, Mahapatra TK, McManus PL, Fox JN, Drew PJ (2007) Surgery is associated with lower morbidity and longer survival in elderly breast cancer patients over 80. Breast J 13:368–373

    Article  PubMed  Google Scholar 

  5. Molino A, Giovannini M, Auriemma A, Fiorio E, Mercanti A, Mandara M et al (2006) Pathological, biological and clinical characteristics, and surgical management, of elderly women with breast cancer. Crit Rev Oncol Hematol 59:226–233

    Article  PubMed  Google Scholar 

  6. Blanks R, Moss S, McGahan C, Quinn M, Babb P (2000) Effect of NHS breast screening programme on mortality from breast cancer in England and Wales, 1990-8: comparison of observed with predicted mortality. BMJ 321:665–669

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Audisio RA (2008) Shall we operate? Preoperative assessment in elderly cancer patients (PACE) can help. A SIOG surgical task force prospective study. Crit Rev Oncol Hematol

  8. Mohile SG, Magnuson A (2013) Comprehensive geriatric assessment in oncology. Interdiscip Top Gerontol 38:85–103

    Article  PubMed  Google Scholar 

  9. Kimmick GG, Major B, Clapp J, Sloan J, Pitcher B, Ballman K, Barginear M, Freedman RA, Artz A, Klepin HD, Lafky JM, Hopkins J, Winer E, Hudis C, Muss H, Cohen H, Jatoi A, Hurria A, Mandelblatt J (2017) Using ePrognosis to estimate 2-year all-cause mortality in older women with breast cancer: Cancer and Leukemia Group B (CALGB) 49907 and 369901 (Alliance A151503). Breast Cancer Res Treat 163:391–398

    Article  PubMed  PubMed Central  Google Scholar 

  10. Walter LC, Brand RJ, Counsell SR, Palmer RM, Landefeld CS, Fortinsky RH, Covinsky KE (2001) Development and validation of a prognostic index for 1-year mortality in older adults after hospitalization. JAMA 285:2987–2994

    Article  CAS  PubMed  Google Scholar 

  11. Fu MR, Axelrod D, Guth AA, Cleland CM, Ryan CE, Weaver KR, Qiu J, Kleinman R, Scagliola J, Palamar J, Melkus G (2015) Comorbidities and quality of life among breast cancer survivors: a prospective study. J Pers Med 5:229–242

    Article  PubMed  PubMed Central  Google Scholar 

  12. Charlson M (1987) Charlson comorbidity index. J Chronic Dis 40(5):373–383

    Article  CAS  PubMed  Google Scholar 

  13. Bowling A, Hankins M, Windle G, Bilotta C, Grant R (2013) A short measure of quality of life in older age: the performance of the brief Older People’s Quality of Life questionnaire (OPQOL-brief). Arch Gerontol Geriatr 56:181–187

    Article  PubMed  Google Scholar 

  14. De Glas N, Bastiaannet E, Engels C, De Craen A, Putter H, Van De Velde C et al (2016) Validity of the online PREDICT tool in older patients with breast cancer: a population-based study. Br J Cancer 114:395–400

    Article  PubMed  PubMed Central  Google Scholar 

  15. Albert JM, Liu DD, Shen Y, Pan I-W, Shih Y-CT, Hoffman KE, Buchholz TA, Giordano SH, Smith BD (2012) Nomogram to predict the benefit of radiation for older patients with breast cancer treated with conservative surgery. J Clin Oncol 30:2837–2843

    Article  PubMed  PubMed Central  Google Scholar 

  16. Ozanne EM, Braithwaite D, Sepucha K, Moore D, Esserman L, Belkora J (2009) Sensitivity to input variability of the adjuvant! Online breast cancer prognostic model. J Clin Oncol 27:214–219

    Article  PubMed  Google Scholar 

  17. Mandelblatt JS, Cai L, Luta G, Kimmick G, Clapp J, Isaacs C, Pitcher B, Barry W, Winer E, Sugarman S, Hudis C, Muss H, Cohen HJ, Hurria A (2017) Frailty and long-term mortality of older breast cancer patients: CALGB 369901 (Alliance). Breast Cancer Res Treat 164:107–117

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Hurria A, Mohile S, Gajra A, Klepin H, Muss H, Chapman A, Feng T, Smith D, Sun CL, de Glas N, Cohen HJ, Katheria V, Doan C, Zavala L, Levi A, Akiba C, Tew WP (2016) Validation of a prediction tool for chemotherapy toxicity in older adults with cancer. J Clin Oncol 34:2366–2371

    Article  PubMed  PubMed Central  Google Scholar 

  19. Extermann M, Boler I, Reich RR, Lyman GH, Brown RH, DeFelice J, Levine RM, Lubiner ET, Reyes P, Schreiber FJ III, Balducci L (2012) Predicting the risk of chemotherapy toxicity in older patients: the chemotherapy risk assessment scale for high-age patients (CRASH) score. Cancer 118:3377–3386

    Article  PubMed  Google Scholar 

  20. Kuhl CK, Schrading S, Leutner CC, Morakkabati-Spitz N, Wardelmann E, Fimmers R, Kuhn W, Schild HH (2005) Mammography, breast ultrasound, and magnetic resonance imaging for surveillance of women at high familial risk for breast cancer. J Clin Oncol 23:8469–8476

    Article  PubMed  Google Scholar 

  21. Kerlikowske K, Grady D, Rubin SM, Sandrock C, Ernster VL (1995) Efficacy of screening mammography: a meta-analysis. JAMA 273:149–154

    Article  CAS  PubMed  Google Scholar 

  22. Braithwaite D, Demb J, Henderson LM (2016) Optimal breast cancer screening strategies for older women: current perspectives. Clin Interv Aging 11:111–125

    Article  PubMed  PubMed Central  Google Scholar 

  23. Teh W, Wilson A (1998) The role of ultrasound in breast cancer screening. A consensus statement by the European Group for Breast Cancer Screening. Eur J Cancer 34:449–450

    Article  CAS  PubMed  Google Scholar 

  24. Kopans DB (2004) Sonography should not be used for breast cancer screening until its efficacy has been proven scientifically. Am J Roentgenol 182:489–491

    Article  Google Scholar 

  25. Berg WA, Blume JD, Cormack JB, Mendelson EB, Lehrer D, Böhm-Vélez M, Pisano ED, Jong RA, Evans WP, Morton MJ, Mahoney MC, Larsen LH, Barr RG, Farria DM, Marques HS, Boparai K, ACRIN 6666 Investigators (2008) Combined screening with ultrasound and mammography vs mammography alone in women at elevated risk of breast cancer. JAMA 299:2151–2163

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  26. Eisenbrey JR, Dave JK, Forsberg F (2016) Recent technological advancements in breast ultrasound. Ultrasonics 70:183–190

    Article  CAS  PubMed  Google Scholar 

  27. Pilewskie M, Hirsch A, Eaton A, Stempel M, Morris E, Gemignani ML (2015) Breast cancer in the elderly: is MRI helpful? Breast J 21:651–657

    Article  PubMed  PubMed Central  Google Scholar 

  28. Bach AG, Abbas J, Jasaabuu C, Schramm D, Wienke A, Surov A (2013) Comparison between incidental malignant and benign breast lesions detected by computed tomography: a systematic review. J Med Imaging Radiat Oncol 57:529–533

    Article  PubMed  Google Scholar 

  29. De Placido S, De Angelis C, Giuliano M, Pizzi C, Ruocco R, Perrone V et al (2017) Imaging tests in staging and surveillance of non-metastatic breast cancer: changes in routine clinical practice and cost implications. Br J Cancer 116:821–827

    Article  PubMed  PubMed Central  Google Scholar 

  30. Kiderlen M, Bastiaannet E, Walsh PM, Keating NL, Schrodi S, Engel J, van de Water W, Ess SM, van Eycken L, Miranda A, de Munck L, van de Velde CJH, de Craen AJM, Liefers GJ (2012) Surgical treatment of early stage breast cancer in elderly: an international comparison. Breast Cancer Res Treat 132:675–682

    Article  CAS  PubMed  Google Scholar 

  31. Fennessy M, Bates T, MacRae K, Riley D, Houghton J, Baum M (2004) Late follow-up of a randomized trial of surgery plus tamoxifen versus tamoxifen alone in women aged over 70 years with operable breast cancer. Br J Surg 91:699–704

    Article  CAS  PubMed  Google Scholar 

  32. Albrand G, Terret C (2008) Early breast cancer in the elderly: assessment and management considerations. Drugs Aging 25:35–45

    Article  CAS  PubMed  Google Scholar 

  33. Lavelle K, Todd C, Moran A, Howell A, Bundred N, Campbell M (2007) Non-standard management of breast cancer increases with age in the UK: a population based cohort of women > or =65 years. Br J Cancer 96:1197–1203

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  34. Martelli G, Miceli R, Daidone MG, Vetrella G, Cerrotta AM, Piromalli D, Agresti R (2011) Axillary dissection versus no axillary dissection in elderly patients with breast cancer and no palpable axillary nodes: results after 15 years of follow-up. Ann Surg Oncol 18:125–133

    Article  PubMed  Google Scholar 

  35. Boughey JC, Haffty BG, Habermann EB, Hoskin TL, Goetz MP (2017) Has the time come to stop surgical staging of the axilla for all women age 70 years or older with hormone receptor-positive breast cancer? Ann Surg Oncol 24:614–617

    Article  PubMed  Google Scholar 

  36. Hebert-Croteau N, Brisson J, Latreille J, Rivard M, Abdelaziz N, Martin G (2004) Compliance with consensus recommendations for systemic therapy is associated with improved survival of women with node-negative breast cancer. J Clin Oncol 22:3685–3693

    Article  PubMed  Google Scholar 

  37. Fentiman IS, Christiaens MR, Paridaens R, Van Geel A, Rutgers E, Berner J et al (2003) Treatment of operable breast cancer in the elderly: a randomised clinical trial EORTC 10851 comparing tamEur J Cancer (Oxford, England : 1990)oxifen alone with modified radical mastectomy. 39:309–316

  38. Weggelaar I, Aben KK, Warle MC, Strobbe LJ, van Spronsen DJ (2011) Declined guideline adherence in older breast cancer patients: a population-based study in the Netherlands. Breast J 17:239–245

    Article  PubMed  Google Scholar 

  39. Early Breast Cancer Trialists’ Collaborative G (2005) Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Lancet 365:1687–1717

    Article  CAS  Google Scholar 

  40. Thurlimann B, Keshaviah A, Coates AS, Mouridsen H, Mauriac L, Forbes JF et al (2005) A comparison of letrozole and tamoxifen in postmenopausal women with early breast cancer. N Engl J Med 353:2747–2757

    Article  PubMed  Google Scholar 

  41. Johnston SJ, Kenny FS, Syed BM, Robertson JF, Pinder SE, Winterbottom L et al (2012) A randomised trial of primary tamoxifen versus mastectomy plus adjuvant tamoxifen in fit elderly women with invasive breast carcinoma of high oestrogen receptor content: long-term results at 20 years of follow-up. Ann Oncol 23:2296–2300

    Article  CAS  PubMed  Google Scholar 

  42. Berry DA, Cirrincione C, Henderson IC, Citron ML, Budman DR, Goldstein LJ, Martino S, Perez EA, Muss HB, Norton L, Hudis C, Winer EP (2006) Estrogen-receptor status and outcomes of modern chemotherapy for patients with node-positive breast cancer. JAMA 295:1658–1667

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  43. Muss HB, Woolf S, Berry D, Cirrincione C, Weiss RB, Budman D, Wood WC, Henderson IC, Hudis C, Winer E, Cohen H, Wheeler J, Norton L, Cancer and Leukemia Group B (2005) Adjuvant chemotherapy in older and younger women with lymph node-positive breast cancer. JAMA 293:1073–1081

    Article  CAS  PubMed  Google Scholar 

  44. Palmeri S, Berretta M, Palmeri L (2013) Medical treatment of elderly patients with breast cancer. Anti Cancer Agents Med Chem 13:1325–1331

    Article  CAS  Google Scholar 

  45. Buchholz TA (2011) Radiotherapy and survival in breast cancer. Lancet 378:1680–1682

    Article  PubMed  Google Scholar 

  46. Giuliano AE, Hunt KK, Ballman KV, Beitsch PD, Whitworth PW, Blumencranz PW, Leitch AM, Saha S, McCall L, Morrow M (2011) Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial. JAMA 305:569–575

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  47. Darby S, McGale P, Correa C, Taylor C, Arriagada R, Clarke M et al (2011) Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10,801 women in 17 randomised trials. Lancet 378:1707–1716

    Article  CAS  PubMed  Google Scholar 

  48. Chesney TR, Yin JX, Rajaee N, Tricco AC, Fyles AW, Acuna SA et al (2017) Tamoxifen with radiotherapy compared with Tamoxifen alone in elderly women with early-stage breast cancer treated with breast conserving surgery: a systematic review and meta-analysis. Radiother Oncol 123:1–9

    Article  CAS  PubMed  Google Scholar 

  49. Vaidya JS, Wenz F, Bulsara M, Tobias JS, Joseph DJ, Saunders C, Brew-Graves C, Potyka I, Morris S, Vaidya HJ, Williams NR, Baum M (2016) An international randomised controlled trial to compare TARGeted Intraoperative radioTherapy (TARGIT) with conventional postoperative radiotherapy after breast-conserving surgery for women with early-stage breast cancer (the TARGIT-A trial). Health Technol Assess 20:1–188

    Article  PubMed  PubMed Central  Google Scholar 

  50. Pollock YG, Blackford AL, Jeter SC, Wright J, Cimino-Mathews A, Camp M et al (2016) Adjuvant radiation use in older women with early-stage breast cancer at Johns Hopkins. Breast Cancer Res Treat 160:291–296

    Article  CAS  PubMed  Google Scholar 

  51. Meresse M, Bouhnik AD, Bendiane MK, Retornaz F, Rousseau F, Rey D, Giorgi R (2017) Chemotherapy in old women with breast cancer: is age still a predictor for under treatment? Breast J 23:256–266

    Article  PubMed  Google Scholar 

  52. Clarke M, Coates AS, Darby SC, Davies C, Gelber RD, Godwin J et al (2008) Adjuvant chemotherapy in oestrogen-receptor-poor breast cancer: patient-level meta-analysis of randomised trials. Lancet 371:29–40

    Article  CAS  PubMed  Google Scholar 

  53. Kaplan HG, Malmgren JA, Atwood MK (2017) Triple-negative breast cancer in the elderly: prognosis and treatment. Breast J 23:630–637

    Article  CAS  PubMed  Google Scholar 

  54. Neyt M, Albrecht J, Cocquyt V (2006) An economic evaluation of Herceptin® in adjuvant setting: the Breast Cancer International Research Group 006 trial. Ann Oncol 17:381–390

    Article  CAS  PubMed  Google Scholar 

  55. Hornova J, Bortlicek Z, Majkova P, Abrahamova J, Kordikova D, Donatova Z, Kupec M, Boublikova L, Dvorak J, Zapletal R, Buchler T (2017) Locally advanced breast cancer in elderly patients. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 161:217–222

    Article  PubMed  Google Scholar 

  56. Cabarrou B, Mourey L, Dalenc F, Balardy L, Kanoun D, Roché H, Boher JM, Rougé-Bugat ME, Filleron T (2017) Methodology of phase II clinical trials in metastatic elderly breast cancer: a literature review. Breast Cancer Res Treat 164:505–513

    Article  CAS  PubMed  Google Scholar 

  57. Hamelinck VC, Stiggelbout AM, van de Velde CJH, Liefers GJ, Bastiaannet E (2017) Treatment recommendations for older women with breast cancer: a survey among surgical, radiation and medical oncologists. Eur J Surg Oncol 43:1288–1296

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Chwanrow Karim Baban.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical approval

This article does not contain any studies with human participants or animals performed by any of the authors.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Baban, C.K., Devane, L. & Geraghty, J. Change of paradigm in treating elderly with breast cancer: are we undertreating elderly patients?. Ir J Med Sci 188, 379–388 (2019). https://doi.org/10.1007/s11845-018-1851-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11845-018-1851-9

Keywords

Navigation